However, the alteration of body weight or condition of obesity does not seem to be related to the LPA1 and LPA3-mediated diabetic abnormal pain behaviors, since the HFD-fed and db/db mice have increased body weight, while STZ-treated mice have decreased one. The gene discussed is LPAR3; the disease is obesity disorder.